Related Experiment Video

Updated: May 18, 2026

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

Biological rationale for the design of polymeric anti-cancer nanomedicines

Yan Zhou1, Jindřich Kopeček

  • 1Department of Pharmaceutics and Pharmaceutical Chemistry, University of Utah, Salt Lake City, UT 84112, USA.

Journal of Drug Targeting
|September 27, 2012
PubMed

Insights

This review explores how cancer biology, including heterogeneity and metastasis, impacts nanomedicine delivery. It discusses strategies for polymeric nanomedicines to overcome these challenges for better cancer treatment.

Area of Science:

  • Oncology
  • Nanomedicine
  • Biotechnology

Background:

  • Cancer biology presents unique challenges for nanomedicine efficacy.
  • Key factors include tumor heterogeneity, cancer stem cells, tumor microenvironment complexity, and metastasis.
  • Understanding these biological features is crucial for developing effective anti-cancer nanomedicines.

Purpose of the Study:

  • To review critical cancer biological properties that challenge current nanomedicine treatments.
  • To discuss the biological basis of targeting strategies like the enhanced permeability and retention (EPR) effect and active targeting.
  • To explore nanomedicine strategies for overcoming delivery barriers and improving therapeutic payload interactions.

Main Methods:

  • Literature review focusing on cancer biology and nanomedicine design.
  • Analysis of challenges posed by tumor heterogeneity, cancer stem cells, tumor microenvironment, and metastasis.
  • Discussion of passive (EPR effect) and active targeting strategies and their physiological barriers.

Main Results:

  • Cancer's complex biology significantly impacts nanomedicine delivery and efficacy.
  • The enhanced permeability and retention (EPR) effect and active targeting have specific biological underpinnings.
  • Physiological barriers impede both passive and active nanomedicine targeting.

Conclusions:

  • Designing effective anti-cancer nanomedicines requires a deep understanding of cancer biology.
  • Strategies targeting cancer heterogeneity, stem cells, and metastasis are essential.
  • Overcoming delivery barriers and enhancing payload interaction are key for polymeric nanomedicine development.

More Related Videos

Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery09:09

Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery

Published on: June 23, 2020

Manufacture and Drug Delivery Applications of Silk Nanoparticles09:03

Manufacture and Drug Delivery Applications of Silk Nanoparticles

Published on: October 8, 2016

Related Concept Videos

Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...